scholarly article | Q13442814 |
P356 | DOI | 10.3727/096368910X522270 |
P698 | PubMed publication ID | 20719086 |
P2093 | author name string | Yi-Ming Shyr | |
Chie-Pein Chen | |||
Jia-Fwu Shyu | |||
Hwai-Shi Wang | |||
Tien-Hua Chen | |||
Kam-Tsun Tang | |||
Seng-Wong Huang | |||
Wen-Sheng Shen | |||
Hsin-Chi Hsu | |||
Torng-Chien Chi | |||
P433 | issue | 3 | |
P921 | main subject | stem cell transplantation | Q65592366 |
umbilical cord mesenchymal stem cell | Q107296590 | ||
P304 | page(s) | 455-466 | |
P577 | publication date | 2010-08-18 | |
P1433 | published in | Cell Transplantation | Q15761863 |
P1476 | title | Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice | |
P478 | volume | 20 |
Q26746977 | Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells |
Q61443550 | Applications of stem cells and bioprinting for potential treatment of diabetes |
Q90412554 | Comparison between the therapeutic effects of differentiated and undifferentiated Wharton's jelly mesenchymal stem cells in rats with streptozotocin-induced diabetes |
Q35942076 | Comparisons of Differentiation Potential in Human Mesenchymal Stem Cells from Wharton's Jelly, Bone Marrow, and Pancreatic Tissues |
Q41074329 | Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo. |
Q41698876 | Differentiation of Human Mesenchymal Stem Cells into Insulin Producing Cells by Using A Lentiviral Vector Carrying PDX1. |
Q89147848 | Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells |
Q36576142 | Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules |
Q33726367 | From Human Mesenchymal Stem Cells to Insulin-Producing Cells: Comparison between Bone Marrow- and Adipose Tissue-Derived Cells |
Q35048202 | Generation of functional insulin-producing cells from neonatal porcine liver-derived cells by PDX1/VP16, BETA2/NeuroD and MafA. |
Q52575667 | Human urine-derived stem cells play a novel role in the treatment of STZ-induced diabetic mice. |
Q64885196 | IL-1β-Induced Matrix Metalloprotease-1 Promotes Mesenchymal Stem Cell Migration via PAR1 and G-Protein-Coupled Signaling Pathway. |
Q37734573 | Immunogenicity of insulin-producing cells derived from human umbilical cord mesenchymal stem cells |
Q84090337 | Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells |
Q53535050 | In vitro evaluation of different protocols for the induction of mesenchymal stem cells to insulin-producing cells. |
Q34066303 | Induction of highly functional hepatocytes from human umbilical cord mesenchymal stem cells by HNF4α transduction |
Q37483420 | Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice |
Q35307069 | Intravenous transplantation of very small embryonic like stem cells in treatment of diabetes mellitus |
Q26864580 | Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus |
Q38782963 | Mesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus |
Q38114073 | Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges |
Q37512295 | Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. |
Q59790769 | Overexpression of apelin in Wharton' jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats |
Q92366771 | Overexpression of long noncoding RNA CUDR promotes hepatic differentiation of human umbilical cord mesenchymal stem cells |
Q37904841 | Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion |
Q34117889 | Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetes |
Q26825664 | Recent developments in β-cell differentiation of pluripotent stem cells induced by small and large molecules |
Q92247218 | Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs) |
Q34391056 | Stem cell transplantation improves aging-related diseases |
Q42324113 | Stem cells as a tool to improve outcomes of islet transplantation |
Q37030974 | Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells |
Q89619953 | Three-Dimensional Culture Promotes the Differentiation of Human Dental Pulp Mesenchymal Stem Cells Into Insulin-Producing Cells for Improving the Diabetes Therapy |
Q36116497 | Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats |
Q41952750 | Transplantation of insulin-producing cells to treat diabetic rats after 90% pancreatectomy |
Q40321403 | Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study |
Q41935677 | Umbilical Cord Derived Mesenchymal Stem Cells Useful in Insulin Production - Another Opportunity in Cell Therapy |
Q43027093 | Utility of co-transplanting mesenchymal stem cells in islet transplantation. |
Q37802776 | Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes |
Search more.